A paradigm shift in approach to antimicrobials is neededBMJ 2013; 346 doi: http://dx.doi.org/10.1136/bmj.f2138 (Published 10 April 2013) Cite this as: BMJ 2013;346:f2138
- Richard L Puleston, associate professor of public health1, honorary consultant2
- 1University of Nottingham, Nottingham, UK
- 2Health Protection Agency East Midlands, City Hospital, Nottingham NG5 1PB, UK
The focus on antimicrobial resistance highlights the challenges of providing healthcare when antibiotic effectiveness has changed.1 Improved antibiotic stewardship is important, but new agents are also needed, especially to treat inherently resistant organisms (Acinetobacter baumannii) and those acquiring new resistance mechanisms (Escherichia coli and Klebsiella spp), yet the pipeline of new antimicrobials is running dry.
Economics explains why few antimicrobials are in …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial